Urokinase plasminogen activator receptor (uPAR) and plasminogen activator inhibitor-1 (PAI-1) are potential predictive biomarkers in early stage oral squamous cell carcinomas (OSCC) (Q33856467)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Urokinase plasminogen activator receptor (uPAR) and plasminogen activator inhibitor-1 (PAI-1) are potential predictive biomarkers in early stage oral squamous cell carcinomas (OSCC)	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

Urokinase plasminogen activator receptor (uPAR) and plasminogen activator inhibitor-1 (PAI-1) are potential predictive biomarkers in early stage oral squamous cell carcinomas (OSCC) (English)

1 reference

Europe PubMed Central

29 July 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Synnøve Magnussen

1

1 reference

Europe PubMed Central

29 July 2017

Oddveig G Rikardsen

2

1 reference

Europe PubMed Central

29 July 2017

Elin Hadler-Olsen

3

1 reference

Europe PubMed Central

29 July 2017

Lars Uhlin-Hansen

4

1 reference

Europe PubMed Central

29 July 2017

Sonja E Steigen

5

1 reference

Europe PubMed Central

29 July 2017

Gunbjørg Svineng

6

1 reference

Europe PubMed Central

29 July 2017

language of work or name

0 references

publication date

7 July 2014

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

9

1 reference

Europe PubMed Central

29 July 2017

7

1 reference

Europe PubMed Central

29 July 2017

e101895

1 reference

Europe PubMed Central

29 July 2017

copyright license

Creative Commons Attribution 4.0 International

7 July 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Prognostic molecular markers in cancer - quo vadis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

Correlation between Ki67 and breast cancer prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

PAI-1: An Integrator of Cell Signaling and Migration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

Cancer therapy trials employing level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

Prognostic significance of immunohistochemical biomarkers in oral squamous cell carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

The molecular biology of head and neck cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

Co-detection of members of the urokinase plasminogen activator system in tumour tissue and serum correlates with a poor prognosis for soft-tissue sarcoma patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

Gelatin in situ zymography on fixed, paraffin-embedded tissue: zinc and ethanol fixation preserve enzyme activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

The urokinase plasminogen activator system: a target for anti-cancer therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

Prognostic value analysis of urokinase-type plasminogen activator receptor in oral squamous cell carcinoma: an immunohistochemical study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

Urinary-type plasminogen activator (uPA) and its receptor (uPAR) in squamous cell carcinoma of the oral cavity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

uPAR-induced cell adhesion and migration: vitronectin provides the key

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

Oral squamous cell carcinoma: review of prognostic and predictive factors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

Epithelial hyaluronic acid and CD44v6 are mutually involved in invasion of colorectal adenocarcinomas and linked to patient prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

Focus on head and neck cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

Disparity in pathologic and clinical lymph node staging in oral tongue carcinoma. Implication for therapeutic decision making

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

Prognostic relevance of molecular markers of oral cancer--a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

Oral cancer and precancerous lesions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

The plasminogen activation system in tumor growth, invasion, and metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

Immunohistochemical localization of a urokinase-type plasminogen activator system in squamous cell carcinoma of the oral cavity: association with mode of invasion and lymph node metastasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

Characterization of urokinase receptor expression by human placental trophoblasts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

5 July 2018

Tumour-associated urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in normal and neoplastic tissues of patients with squamous cell cancer of the oral cavity - clinical relevance and prognostic value

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0101895

21 January 2018

Expression of plasminogen activator inhibitor-1, urokinase receptor and laminin gamma-2 chain is an early coordinated event in incipient oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0101895

21 January 2018

Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0101895

21 January 2018

REporting recommendations for tumor MARKer prognostic studies (REMARK).

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0101895

21 January 2018

Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0101895

21 January 2018

Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084992

29 October 2018

Plasminogen activator system in oral squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24999729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasminogen activator inhibitor types 1 and 2 in human trophoblasts. PAI-1 is an immunocytochemical marker of invading trophoblasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/24999729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/24999729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/24999729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24999729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localization of plasminogen activators and their inhibitor in squamous cell carcinomas of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/24999729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Staining characterization by immunohistochemistry of tumor cancer antigen in patients with endometrial cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24999729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of Ki-67 expression in oral squamous cell carcinoma: why Ki-67 is not a prognostic indicator

1 reference

https://pubmed.ncbi.nlm.nih.gov/24999729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elective neck treatment versus observation in patients with T1/T2 N0 squamous cell carcinoma of oral tongue

1 reference

https://pubmed.ncbi.nlm.nih.gov/24999729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/24999729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral squamous cell carcinoma and a clinically negative neck: The value of follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/24999729

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0101895

1 reference

Europe PubMed Central

29 July 2017

2014PLoSO...9j1895M

0 references

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33856467&oldid=1861273694"